Back

DMPKformer: An Interpretable Multimodal Deep Learning Framework for Reliable ADMET Property Prediction

A. S., B. G.; Singh, A.; Kanchan, S.; Anapat, S.; Gurram, K.; Kulkarni, N. M.

2026-05-29 bioinformatics
10.64898/2026.05.28.728612 bioRxiv
Show abstract

Accurate prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties remains a critical challenge in drug discovery. Traditional single modality approaches often fail to capture the complex, multi-scale relationships governing molecular behavior across physicochemical, structural, and pharmacokinetic dimensions. In this work, we propose a multi-modal deep learning framework that integrates complementary molecular representations, MACCS fingerprints, molecular graphs, and physicochemical descriptors to achieve robust ADMET property prediction. Each modality is modeled using a specialized neural subnetwork tailored to its structural characteristics: a self-attention-based Transformer encoder for MACCS fingerprints, a Graph Attention Network (GAT) for molecular graph representations, and a tanh-activated multilayer perceptron for RDKit-, PaDEL-, and Mordred-derived descriptors. Each modality is independently trained for binary classification, and latent embeddings extracted from internal layers serve as transferable molecular representations. These embeddings are subsequently fused and fine-tuned via a tanh-activated dense network and shared prediction head to form a unified ADMET predictor. The proposed framework achieves competitive performance across multiple TDC ADMET benchmarks while providing enhanced interpretability through modality-specific attention mechanisms. In addition, the incorporation of latent-space out-of-distribution (OOD) confidence estimation enables identification of high-confidence operating regions, improving the reliability and practical applicability of the framework for molecular property prediction in drug discovery workflows.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Journal of Chemical Information and Modeling
207 papers in training set
Top 0.1%
33.1%
2
Bioinformatics
1061 papers in training set
Top 4%
6.8%
3
Advanced Science
249 papers in training set
Top 3%
6.4%
4
Journal of Cheminformatics
25 papers in training set
Top 0.1%
6.4%
50% of probability mass above
5
Briefings in Bioinformatics
326 papers in training set
Top 0.8%
6.3%
6
Computational and Structural Biotechnology Journal
216 papers in training set
Top 1%
4.0%
7
Nature Communications
4913 papers in training set
Top 39%
3.7%
8
Nature Machine Intelligence
61 papers in training set
Top 2%
1.9%
9
Communications Chemistry
39 papers in training set
Top 0.2%
1.8%
10
Scientific Reports
3102 papers in training set
Top 57%
1.7%
11
Communications Biology
886 papers in training set
Top 8%
1.7%
12
PLOS Computational Biology
1633 papers in training set
Top 16%
1.7%
13
IEEE Journal of Biomedical and Health Informatics
34 papers in training set
Top 1%
1.3%
14
npj Systems Biology and Applications
99 papers in training set
Top 2%
1.1%
15
PLOS ONE
4510 papers in training set
Top 62%
1.0%
16
Computers in Biology and Medicine
120 papers in training set
Top 4%
0.9%
17
IEEE Transactions on Computational Biology and Bioinformatics
17 papers in training set
Top 0.5%
0.8%
18
Artificial Intelligence in the Life Sciences
11 papers in training set
Top 0.2%
0.7%
19
Metabolites
50 papers in training set
Top 1%
0.7%
20
BMC Bioinformatics
383 papers in training set
Top 7%
0.7%
21
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 45%
0.7%
22
Patterns
70 papers in training set
Top 2%
0.7%
23
International Journal of Molecular Sciences
453 papers in training set
Top 16%
0.7%
24
Quantitative Biology
11 papers in training set
Top 0.8%
0.7%
25
Nucleic Acids Research
1128 papers in training set
Top 20%
0.6%
26
Genome Medicine
154 papers in training set
Top 9%
0.6%
27
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 7%
0.6%
28
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.9%
0.6%